OncLive TV

Dr. Eric Sherman from Memorial Sloan-Kettering Cancer Center Discusses the Vandetanib Trial

Dr. Ranee Mehra from Fox Chase Cancer Center Discusses DNA Repair Enzymes

Dr. Robert Alter from John Theurer Cancer Center Discusses Provenge MOA and Tolerability

Dr. Wayne Bardwell from UCSD Cancer Center Expresses the Importance of Listening

Dr. Julia White from Community Memorial Hospital Discusses Exceptions in the Z11 Trial

Dr. Daniel Petrylak from Herbert Irving Comprehensive Cancer Center Discusses Sequencing Prostate Cancer Therapies

Dr. Maurie Markman from Cancer Treatment Centers of America Discusses Diagnostic Molecular Testing

Dr. Emily Chan from Vanderbilt-Ingram Cancer Center Discusses the Adjuvant Colorectal NO147 Trial

Dr. Oliver Sartor from Tulane Cancer Center Discusses Prostate Cancer Drug Combinations

Dr. Ezra Cohen from the University of Chicago Discusses Head and Neck Cancer Pathways

Dr. Ken Fleisher from New York University Discusses Monitoring Patients With ONJ

Dr. Volker Diehl from the University of Cologne Discusses Brentuximab Vedotin

Dr. James Berenson from the Institute for Myeloma & Bone Cancer Research Discusses the Carfilzomib Toxicity Profile

Dr. Adam Brufsky from the University of Pittsburgh School of Medicine Advises Doctors on Bevacizumab (Avastin) for Breast Cancer

Dr. Beth DuPree from Holy Redeemer Health System Provides Z11 Trial Takeaway Points

Dr. Brian I. Rini from the Cleveland Clinic Discusses the VEGF Targeted Agent Axitinib

Dr. Robert Alter from John Theurer Cancer Center Discusses the Provenge Treatment Process

Dr. Maurie Markman from Cancer Treatment Centers of America Discusses the Importance of Diagnostic Testing

Dr. Kenneth Fleisher from NYU College of Dentistry Explains How Nurses Can Identify osteonecrosis of the jaw.

Dr. Julia R. White from the Medical College of Wisconsin, Discusses the Z11 Trial Radiation Findings

Dr. Oliver Sartor from Tulane Cancer Center Discusses the Novel Agent Radium-223

Dr. Adam Brufsky from University of Pittsburgh School of Medicine, Discusses Bevacizumab Benefits in TNBC

Dr. Volker Diehl from the University of Cologne, Germany, Compares US and EU Hodgkin Lymphoma Staging

Dr. Robert Alter from John Theurer Cancer Center Discusses the Immunotherapy Provenge

Dr. Axel Grothey from the Mayo Clinic Discusses Novel Agents for Colorectal Cancer

Dr. James Berenson from the Institute for Myeloma and Bone Cancer Research Discusses the Proteasome Inhibitor Carfilzomib

Dr. Volker Diehl from the University of Cologne, Germany on the Unique Nature of Hodgkin's Lymphoma

Dr. Axel Grothey from the Mayo Clinic on Trastuzumab for Gastroesophageal Cancer

Dr. Andre Goy from John Theurer Cancer Center Explains the Concept of Personalized Medicine

Dr. Sean Grimm from Northwestern University, Feinberg School of Medicine on MGMT as a Predictive Marker in Brain Cancer